Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Dana Chitu"'
Autor:
Marie José Kersten, Martin Dreyling, Kim M. Linton, Dana Chitu, Sanne Tonino, Marcel Kap, Roberto D Liu, Martine E.D. Chamuleau, Hein P.J. Visser, Eva De Jongh, Erik WAF Marijt, Maria B.L. Leijs, Yavuz M. Bilgin, Jan Dürig, Pamela McKay, Tjeerd J.F. Snijders, Andrew Pettitt, Monique C. Minnema, Gabriele Prange-Krex, Maria Cuijpers, Lara H. Böhmer, Lidwine W. Tick, Axel Florschütz, Matthijs Silbermann, Rob Fijnheer, Aart Beeker, Nelleke Tolboom, Cristina Mitea, Anne IJ Arens, Gerben JC Zwezerijnen, Wolfram Klapper, Sarah E. Coupland, Daphne de Jong, Jeanette K. Doorduijn, Josée M. Zijlstra
Publikováno v:
Blood. 140:2283-2285
Autor:
Ron H.J. Mathijssen, Ronald de Wit, Dana Chitu, Nelly van der Meer, Hanneke Zuetenhorst, Albert J. ten Tije, Henk van Halteren, Aart Beeker, Andries M. Bergman, Robbert J. van Alphen, Robert J. van Soest, Sander Bins, Paul Hamberg, Anne-Joy M. de Graan, Annemieke J.M. Nieuweboer
Patient inclusion per participating medical center
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ac0857a031672e41b297902f8aa954f
https://doi.org/10.1158/1078-0432.22464084
https://doi.org/10.1158/1078-0432.22464084
Autor:
Ron H.J. Mathijssen, Ronald de Wit, Dana Chitu, Nelly van der Meer, Hanneke Zuetenhorst, Albert J. ten Tije, Henk van Halteren, Aart Beeker, Andries M. Bergman, Robbert J. van Alphen, Robert J. van Soest, Sander Bins, Paul Hamberg, Anne-Joy M. de Graan, Annemieke J.M. Nieuweboer
Reasons for patients going off-protocol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a968ac59fcc730be5cc55219c07a5d1
https://doi.org/10.1158/1078-0432.22464078.v1
https://doi.org/10.1158/1078-0432.22464078.v1
Autor:
Ron H.J. Mathijssen, Ronald de Wit, Dana Chitu, Nelly van der Meer, Hanneke Zuetenhorst, Albert J. ten Tije, Henk van Halteren, Aart Beeker, Andries M. Bergman, Robbert J. van Alphen, Robert J. van Soest, Sander Bins, Paul Hamberg, Anne-Joy M. de Graan, Annemieke J.M. Nieuweboer
Reasons of inevaluability
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f44a456a75d980de02959594fee7a8d
https://doi.org/10.1158/1078-0432.22464081.v1
https://doi.org/10.1158/1078-0432.22464081.v1
Autor:
Ron H.J. Mathijssen, Ronald de Wit, Dana Chitu, Nelly van der Meer, Hanneke Zuetenhorst, Albert J. ten Tije, Henk van Halteren, Aart Beeker, Andries M. Bergman, Robbert J. van Alphen, Robert J. van Soest, Sander Bins, Paul Hamberg, Anne-Joy M. de Graan, Annemieke J.M. Nieuweboer
Patient diaries' information
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12adbdb4979a840fb452f70dc0b0d887
https://doi.org/10.1158/1078-0432.22464075.v1
https://doi.org/10.1158/1078-0432.22464075.v1
Autor:
Ron H.J. Mathijssen, Ronald de Wit, Dana Chitu, Nelly van der Meer, Hanneke Zuetenhorst, Albert J. ten Tije, Henk van Halteren, Aart Beeker, Andries M. Bergman, Robbert J. van Alphen, Robert J. van Soest, Sander Bins, Paul Hamberg, Anne-Joy M. de Graan, Annemieke J.M. Nieuweboer
Purpose: Forty-seven percent of patients in the pivotal trial of cabazitaxel reported diarrhea of any grade. Aiming to reduce the incidence of diarrhea, we studied the effects of budesonide on the grade of cabazitaxel-induced diarrhea during the firs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::135b34e783102f66d0d037c5cae20e33
https://doi.org/10.1158/1078-0432.c.6525612
https://doi.org/10.1158/1078-0432.c.6525612
Autor:
Michiel Kroesen, Netteke van Holthe, Kemal Sumser, Dana Chitu, Rene Vernhout, Gerda Verduijn, Martine Franckena, Jose Hardillo, Gerard van Rhoon, Margarethus Paulides
Publikováno v:
Cancers, 13(23):6149. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers; Volume 13; Issue 23; Pages: 6149
Cancers
Cancers, Vol 13, Iss 6149, p 6149 (2021)
Cancers; Volume 13; Issue 23; Pages: 6149
Cancers
Cancers, Vol 13, Iss 6149, p 6149 (2021)
Simple Summary Following radiotherapy for head and neck cancer, patients are at risk for developing a recurrent or second tumor. Often reirradiation is required in these patients, which is hampered in dose by the previous irradiation. Besides chemoth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be497ca4938791e67d899f85f395ddb0
https://pure.eur.nl/en/publications/b2b00170-32b1-4ba2-a58c-9eaf55512641
https://pure.eur.nl/en/publications/b2b00170-32b1-4ba2-a58c-9eaf55512641